CordenPharma
Lee Newton serves as the Chief Operating Officer at Corden Pharma since June 2020, overseeing a full-service CDMO specializing in the production of APIs, drug products, and packaging services. Prior to this role, Lee held several significant positions at Lonza, including Senior Vice President and Business Unit Head for API Development & Manufacturing, where leadership extended to P&L responsibilities. Lee's experience also includes a decade at CARBOGEN AMCIS in roles such as Director of Technical Operations, contributing to substantial growth and the establishment of new strategic business units. Career beginnings include positions at NPIL Pharmaceuticals, Avecia, and GlaxoSmithKline, complemented by a PhD in Organic Chemistry and a BSc in Chemistry from Heriot-Watt University.
This person is not in any teams
This person is not in any offices
CordenPharma
1 followers
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com